| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | United States | 7 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Canada | 1 | |
| #6 | Germany | 1 | |
| #7 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Medical preparations | |
| #5 | Measuring microorganism processes | |
| #6 | Object sterilising |
| # | Name | Total Patents |
|---|---|---|
| #1 | Meyer Ralph | 13 |
| #2 | Kandolf Reinhard | 11 |
| #3 | Kuhn Anne | 11 |
| #4 | Kupper Jan-Heiner | 10 |
| #5 | Meyer-Ficca Mirella | 10 |
| #6 | Kuepper Jan-Heiner | 6 |
| #7 | Thorens Bernard | 4 |
| #8 | Dupraz Philippe | 4 |
| #9 | Wong Shou | 4 |
| #10 | Baetge E Edward | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2012200520A1 | Substances causing differentiation | |
| AU2007219361A1 | Substances causing differentiation | |
| US2008064102A1 | Transiently immortalized cells for use in gene therapy | |
| AU2006201883A1 | Tumour-Specific Vector for Gene Therapy | |
| EP1477556A1 | Method for the selection of cardiomyogenic cells or cardiomyocytes from mixed cell populations | |
| WO03035884A2 | Transient immortalization | |
| DE10019195A1 | Reversible immortalization | |
| EP1175436A2 | Transiently immortalized cells for use in gene therapy |